Company intelligence / Profile preview

Avista Pharma Solutions

Durham, North Carolina, USA

Ownership: Private
Employees: ~330
Development stage: Other

Overview

Avista Pharma Solutions was a contract development and manufacturing organization (CDMO) that provided a broad range of services to the pharmaceutical and biopharmaceutical industries. The company offered expertise in drug substance manufacturing, drug product formulation, analytical development, and microbiology testing. With facilities in North Carolina, Colorado, and Massachusetts, Avista supported clients from early-stage discovery through commercial launch. In 2019, the company was acquired by Cambrex to expand its early-stage development and analytical testing capabilities.

Modalities: Small moleculePeptides
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Avista Pharma Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avista Pharma Solutions.

Explore the full profile